Early Human Development
Volume 85, Issue 11 , Pages 727-732 , November 2009

Neonatal hyperbilirubinemia and kernicterus — Not gone but sometimes forgotten

References 

  1. Maisels MJ. Phototherapy — traditional and nontraditional. J Perinatol. 2001;21:S93–S97
  2. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol. 2009;29:S25–S45
  3. Manning D, Todd P, Maxwell M, Platt M-J. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatol Ed. 2007;92:342–346
  4. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213–1217
  5. Sgro M, Campbell DM, Fallah S, Shah V. Kernicterus — January 2007 to December 2009. Canadian Paediatric Surveillance Program 2009;available at: http://www.cps.ca/english/surveillance/CPSP/index.htm.
  6. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730–733
  7. Maimburg RD, Bech BH, Bjerre JV, Olsen J, Moller-Madsen B. Obstetric outcome in Danish children with a validated diagnosis of kernicterus. Acta Obstet Gynecol Scand. 2009;available at: http://dx.doi.org/10.1080/00016340903124917:1-6
  8. Banerjee TKHA, Biswas A, Ray J, Roy T, Raut DK, Chaudhuri A, et al. Neurological disorders in children and adolescents. Indian J Pediatr. 2009;76:139–146
  9. Slusher TM, Vreman HJ, McLaren D, et al. Glucose-6-phosphate dehydrogenase deficiency and carboxy hemoglobin concentrations associated with bilirubin related morbidity and death in Nigerian infants. J Pediatr. 1995;126:102–108
  10. Mezaal MA, Nouri KA, Abdool S, Safar KA, Nadeem ASM. Cerebral palsy in adults consequences of non progressive pathology. Open Neuro J. 2009;3:24–26
  11. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316
  12. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140–1147
  13. Newman T, Liljestrand P, Escobar G. Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159:113–119
  14. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani V. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121:http://www.pediatrics.org/cgi/content/full/121/1/e170:e170-e179
  15. Maisels MJ, DeRidder JM, Kring E, Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol. 2009;29:612–617
  16. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114:e213–e219
  17. Chinevere TD, Murray CK, Grant E, et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. army personnel. Mil Med. 2006;171(9):905–907
  18. Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate. J Perinatol. 2008;28:306–309
  19. Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol. 2009;29:S46–S52
  20. Kaplan M, Renbaum P, Levi-Lahad E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA. 1997;94:12128–12132
  21. Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2000;105:533–537
  22. The American College of Obstetricians and Gynecologists, American Academy of Pediatrics. Neonatal Encephalopathy and Cerebral Palsy. Washington, DC: The American College of Obstetricians and Gynecologists; 2003;
  23. Maisels MJ, Baltz RD, Bhutani VK, Newman TB, Rosenfeld W, Stevenson DK, et al. Neonatal jaundice and kernicterus. Pediatrics. 2001;108:763–765
  24. Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol. 2002;7:135–141
  25. Schneider AP. Breast milk jaundice in the newborn. A real entity. JAMA. 1986;255:3270–3274
  26. Ryan AS, Wenjun MS, Acosta A. Breastfeeding continues to increase into the new millennium. Pediatrics. 2002;110:1103–1109
  27. Dell DL, Sightler SE, Plauche WC. Soft cup vacuum extraction: a comparison of outlet delivery. Obstet Gynecol. 1985;66:624–628
  28. Maisels MJ, Kring EA. Length of stay, jaundice and hospital readmission. Pediatrics. 1998;101:995–998
  29. De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child. 1982;136:737–738
  30. Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24hours after birth in full-term neonates. Pediatrics. 1990;86:171–175
  31. Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation). Paediatr Child Health. 2007;12:1B–12B
  32. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant35weeks' gestation: An update with clarifications. Pediatrics. 2009;124(4):1193–1198
  33. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics. 1999;103:6–14
  34. Longhurst C, Turner S, Burgos AE. Development of a web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines. Jt Comm J Qual Patient Saf. 2009;35(5):256–262
  35. National Quality Forum. Serious Reportable Events in Healthcare: a Consensus Report. Washington, D.C: National Quality Forum; 2002;
  36. Davidson L, Thilo EH. How to make kernicterus a “never event”. Neoreviews. 2003;4:308–314
  37. Kuzniewicz MW, Escobar GJ, Newman TB. The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124(4):1031–1039
  38. Eggert L, Wiedmeier SE, Wilson J, Christensen R. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:e855–e862
  39. Newman TB. Universal bilirubin screening, guidelines, and evidence. Pediatrics. 2009;124(4):1199–1202

PII: S0378-3782(09)00191-1

doi: 10.1016/j.earlhumdev.2009.09.003

Early Human Development
Volume 85, Issue 11 , Pages 727-732 , November 2009